Asia Pacific Synbiotic Products Market

Asia Pacific Synbiotic Products Market Size

The Asia Pacific synbiotic products market size was valued at USD 155.2 million in 2024, and the Asia Pacific market size is expected to reach USD 346.96 million by 2033 from USD 169.72 million in 2025, with a CAGR of 9.35%.

The regional market is supposed to experience moderate growth throughout the forecast period (2025 to 2033). Synbiotic products are food ingredients or food supplements that combine probiotics and prebiotic products. A synbiotic product is a combination of a microorganism that has a beneficial effect on health when consumed. These products often comprise a mixture of Lactobacillus, Bifidobacterium, Streptococcus species, and others, which include lactose, lactulose or inulin.

MARKET OVERVIEW

The Asia Pacific synbiotic market is primarily driven by its wide range of applications in food and beverages, pharmaceuticals, pet food and personal care products due to the nutritional and health benefits they offer. Synbiotics are part of functional foods and beverages and are known to improve intestinal functionality, as well as other benefits, including mental, digestive, immune, and heart health enhancements with synbiotics to provide nutritional and health benefits for key market players has spurred market growth. The main factors expected to drive growth in the Asia Pacific synbiotic products market are increased consumer awareness of health and the rise of nutritional supplements. In addition, disposable income increases, food consumption patterns change, the demand for prebiotics and probiotics in functional foods and beverages increases, and awareness of the benefits of consuming symbiotic products increases, which are other factors that are assumed to drive growth in the Asia Pacific synbiotic products market.

In addition, the growth of the food and beverage sectors, changing consumer preferences, changing living standards with the launch of new advanced and nutritional products, the growth of the dairy industry, government initiatives, and various NGOs promoting the benefits of consuming symbiotic products, are also likely to stimulate growth in the target market during the outlook period. The main players focus on collaborating with other firms to form an efficient distribution chain. Furthermore, the main players are launching new symbiotic products with different natural or organic ingredients to satisfy the growing demand for healthy products, which are some of the key trends observed in the target market, currently. However, strict regulations and product recalls are some of the factors that are anticipated to impede growth in the Asia Pacific synbiotic products market during the prediction period.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Type Insights

Depending on the type, the dietary supplement segment is foreseen to dominate the APAC synbiotic products market due to increased health awareness among consumers.

By Application Insights

According to the application, the food and beverage segment is expected to dominate the target market due to rising catering expenses.

By Packaging Material Insights

Based on packaging materials, paper is expected to dominate the target market, due to the eco-friendly option for packaging symbiotic products.

Distribution Channel Insights

Based on the distribution channel, the store-based segment is presumed to dominate the target market due to broad product availability, and the non-store-based segment is likely to record the highest CAGR due to growth in the e-commerce industry.

REGIONAL ANALYSIS

The market for Asia Pacific synbiotic products has been categorized on the basis of geography into China, Taiwan, South Korea, India, Japan, Australia, and New Zealand, and the rest of the Asia-Pacific. The Asia-Pacific market is expected to be an emerging market for the synbiotic products and is foreseen to have the highest annual growth rate over the projection period due to the rising demand for dietary supplements in countries like China and Indian of this area.

KEY MARKET PLAYERS

Seed Health, Inc, Sabinsa Corporation, Biomin America Inc, Yakult Honsha Co., Ltd, H&H Group, The Kellogg Company, Danone S.A, General Mills, Inc. (US), Pfizer Inc. (US), Daflorn Ltd. (Bulgaria), United Naturals, Probiotical S.p.A. are some of the notable companies in the Asia Pacific Synbiotic Products market.

RECENT HAPPENINGS IN THE MARKET

• In March 2018, a U.S.-based probiotic specialist, Viva 5 Corporation entered into a strategic licensing partnership with NUtech Ventures to be the global distributor of a symbiotic product, which includes a unique human strain of Bifidobacterium adolescentis with a carefully selected galactooligosaccharide (GOS) prebiotic and is Available as a capsule, tablet, stick bar, and powder as a supply. It is either employed as a stand-alone product or in combination with other compatible ingredients.
• In December 2010, Pfizer acquired Synbiotics Corporation for about US$ 20 million in valuation.

MARKET SEGMENTATION

This research report on the Asia Pacific Synbiotic Products market has been segmented and sub-segmented into the following categories.

By Type

• Dietary Supplements
• Drinks
• Sandwiches
• Dairy and frozen desserts
• Bakery and cake shop
• Others (include dry food, feed, fermented meat, etc.)

By Application

• Medication
• Animal food
• Food and Beverages

By Packaging Material

• Paper
• Plastic
• Cup
• Metal

By Distribution Channel

• Store-based
• Non-store based

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC